Status:

ACTIVE_NOT_RECRUITING

The Introduction of a Novel PAOO Technique

Lead Sponsor:

Semmelweis University

Collaborating Sponsors:

NSK Europe GmbH

Conditions:

Bone Loss

Tooth Movement

Eligibility:

All Genders

14-60 years

Phase:

NA

Brief Summary

The aim of this study is to evaluate in a prospective, randomized, controlled clinical trail the effectiveness of preorthodontic piezotomy combined with a buccal bone augmentation (in other name perio...

Detailed Description

Patients presenting teeth crowding in mandibulary or maxillary front area, without ongoing periodontal disease, who require OTM with incisor proclination, are included in the study. Patients are rando...

Eligibility Criteria

Inclusion

  • tooth crowding exceeding a 5mm lack of space (originating from the discrepancy between the overall mesiodostal length of the teeth and the length of the dental arch present at the time of the evaluation)
  • thin bone morphotype (buccal width of the cortical layer must be under 1mm)
  • incisor proclination in order to eliminate crowding without compensatory extractions.
  • informed consent

Exclusion

  • ongoing periodontitis
  • Pregnant women.
  • Participation in another clinical study within 30 days prior to study start.
  • Alcoholism, drug dependency, heavy smoking (\>5 cigarettes/day).
  • Known infection with HIV, HBV, or HCV.
  • Patients requiring chemo- or radiotherapy.
  • Previous or current radiotherapy of the head.
  • Uncontrolled or insulin-dependent diabetes mellitus
  • Clinically relevant osteoporosis or systemic disease affecting bone metabolism
  • Clinically relevant cardiovascular disease e.g., decompensated cardiac insufficiency, hemodynamically relevant heart valve defects, or myocardial infarction during the last three months.
  • Clinically relevant blood coagulation disorder.
  • Previous or current treatment with systemic corticosteroids (within 2 months prior to screening visit) of more than 5 mg/day prednisone equivalent.
  • Previous or current therapy with bisphosphonates at least for 30 days within the last 12 months before screening visit

Key Trial Info

Start Date :

April 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 30 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05264480

Start Date

April 1 2019

End Date

July 30 2025

Last Update

January 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Semmelweis University Department of Periodontology

Budapest, Hungary, 1088